Details of the Drug Reposition

General Information of This Drug (ID: DMAIJC9)

Drug Name
APX-001   DMAIJC9
Synonyms
EPI-0010; SSS-07; Anti-TNF alpha recombinant humanized monoclonal antibody (RabMab/MLG, rheumatoid arthritis), 3SBio/Apexigen; Anti-TNF alpha recombinant humanized monoclonal antibody (RabMab/MLG, rheumatoid arthritis), 3SBio/Epitomics
Structure
3D MOL 2D MOL

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
1 Phase 2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Candidemia DISVKFN7 1F23.3Y Phase 2 [1]
------------------------------------------------------------------------------------
1 Investigative Indication(s)
Indication Name Indication ID ICD-11 Status REF
Rheumatoid arthritis DISTSB4J FA20 Investigative [2]
------------------------------------------------------------------------------------

References

1 ClinicalTrials.gov (NCT03604705) An Efficacy and Safety Study of APX001 in Non-Neutropenic Patients With Candidemia. U.S. National Institutes of Health.
2 The ChEMBL database in 2017. Nucleic Acids Res. 2017 Jan 4;45(D1):D945-D954.